Michael L. Klein
About
In The Last Decade
Michael L. Klein
44 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Ophthalmology 2.1k
- Radiology, Nuclear Medicine and Imaging 1.5k
- Molecular Biology 765
- Biochemistry 171
- Immunology 134
Countries citing papers authored by Michael L. Klein
This map shows the geographic impact of Michael L. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Klein more than expected).
Fields of papers citing papers by Michael L. Klein
This network shows the impact of papers produced by Michael L. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Klein. The network helps show where Michael L. Klein may publish in the future.
Co-authorship network of co-authors of Michael L. Klein
This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Klein. A scholar is included among the top collaborators of Michael L. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Klein. Michael L. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Macular Pigment and Prevalent Inflammatory Disease Among Older Women in the Carotenoids in Age-Related Eye Disease Study (CAREDS), an ancillary study of the Women’s Health Initiative | 2 |
| 3 | The gut microbiome in advanced age-related macular degeneration | 6 |
| 4 | 62 | |
| 5 | 37 | |
| 6 | Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials breakdown → | 489 |
| 7 | 252 | |
| 8 | 141 | |
| 9 | Relationship of Healthy Lifestyles to the Prevalence of Intermediate Age-Related Macular Degeneration (AMD) in the Carotenoids in Age-Related Eye Diseases Study (CAREDS), an Ancillary Study of the Women’s Health Initiative Observational Study (WHIOS) | 1 |
| 10 | 28 | |
| 11 | Relationships Between Vitamin D status and Age-related Macular Degeneration (AMD) in the Carotenoids and Age-Related Eye Disease Study, an Ancillary Study of the Women’s Health Initiative Observational Study (WHIOS) | 1 |
| 12 | C3 Variant Is Associated With Neovascular AMD & Geographic Atrophy in Age-Related Macular Degeneration | 1 |
| 13 | Sequence Analysis of Human AMD Susceptibility Genes in an Aged Nonhuman Primate Population | 1 |
| 14 | 109 | |
| 15 | 55 | |
| 16 | 13 | |
| 17 | 140 | |
| 18 | Determinants of Macular Pigment Density in the Carotenoids in Age–Related Eye Disease Study (CAREDS) an Ancillary Study of the Women's Health Initiative | 1 |
| 19 | Evidence that FIBL-6 is the ARMD1 Gene | 4 |
| 20 | 36 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.